Second life for gene therapy; Takeda Phase 2/3 win; UK cancer biotech’s $83Mnews2026-05-05T15:37:27+00:00May 5th, 2026|Endpoints News|
Swiss manufacturing, biotech industry so far unfazed by geopoliticsnews2026-05-05T14:55:55+00:00May 5th, 2026|Endpoints News|
Purdue Pharma’s opioid prosecution enables bankruptcy settlementnews2026-05-05T14:42:00+00:00May 5th, 2026|Chemistry World|
Pfizer ends Trillium-related development as R&D spend jumpsnews2026-05-05T14:41:28+00:00May 5th, 2026|Endpoints News|
Microbiome startup raises $48M for immunotherapy and malnutrition treatmentsnews2026-05-05T14:30:41+00:00May 5th, 2026|Endpoints News|
J&J’s IBD combo fails Phase 2 studies, but will move into pivotal testingnews2026-05-05T14:30:26+00:00May 5th, 2026|Endpoints News|
